Clinical Efficacy of NST With Local Delivery of Ozonated Olive Versus Curcumin Gel in Stage II Grade B Periodontitis.

NCT ID: NCT07184268

Last Updated: 2025-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-30

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this clinical trial is to evaluate the effectiveness of local delivery ozonated olive gel versus curcumin gel as adjunct to scaling and root planing in the treatment of stage II grade B periodontitis in on both males and females in the age group between 18 and 50 years. outcome measures are Clinical attachment level (CAL), plaque index (PI), gingival index (GI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Periodontitis is an advanced periodontal disease with a distinctive clinical signs and symptoms as rapid attachment loss and bone destruction

The primary treatment approach for periodontitis is mechanical plaque removal through debridement, particularly scaling and root planing (SRP) using hand or ultrasonic instruments.

curcumin gel is an adjunct to non-surgical periodontal therapy is a highly potent local antioxidant and anti-inflammatory agent. While ozone has a potent antimicrobial and anti-inflammatory effects it also can be incorporated into a lipid carrier such as olive oil. Ozone's stability and ease of application are markedly enhanced. Ozonized olive oil can be formulated into a gel with ideal rheological properties for injection into periodontal pockets.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Periodontitis, Adult

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The test group "Group 1" will receive full Scaling and root planing (SRP) followed by subgingival application of ozonated olive gel.

The control group "Group 2" will receive full-mouth SRP followed by subgingival application of curcumin gel
Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

curcumin gel

The curcumin gel will be gently deposited into the periodontal pockets to ensure adequate subgingival delivery.

Group Type ACTIVE_COMPARATOR

full mouth non-surgical scaling

Intervention Type PROCEDURE

All patients will receive a full mouth scaling using ultrasonic scalers and hand instrumentation

ozonated olive gel.

patients will receive subgingival application of ozonated olive oil in the periodontal pocket

Group Type ACTIVE_COMPARATOR

full mouth non-surgical scaling

Intervention Type PROCEDURE

All patients will receive a full mouth scaling using ultrasonic scalers and hand instrumentation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

full mouth non-surgical scaling

All patients will receive a full mouth scaling using ultrasonic scalers and hand instrumentation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients diagnosed with stage II periodontitis defined by having interdental CAL 3-4 mm and presence of pocket depth (PD) ≤ 5 mm, and grade B periodontitis characterized by a moderate rate of disease progression.
2. Patients agree to a 3-month follow-up period and provide an informed consent.

Exclusion Criteria

1. Presence of prosthetic crowns, overhanging restorations and orthodontic treatment.
2. Teeth with both endo-perio lesions.
3. Antibiotics therapy that has an impact on the clinical signs and symptoms of periodontitis in the previous 3 months.
4. Anti-inflammatory drugs in the previous 1 month.

6\. History of systemic disease, allergy, cardiovascular diseases, diabetes mellitus, hypertension, bleeding disorders, hyperparathyroidism, and compromised medical conditions, pregnant and lactating females.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MTI University

OTHER

Sponsor Role collaborator

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Parryhan Mohamed Abdelsamie

Lecturer of periodontology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Parryhan M Abdelsamie

Role: PRINCIPAL_INVESTIGATOR

MTI University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Parryhan M Abdelsamie, PhD

Role: CONTACT

01003082353

Parryhan M Abdelsamie, PhD

Role: CONTACT

01153938582

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

892025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Quercetin in Treatment of Periodontitis
NCT05928546 NOT_YET_RECRUITING PHASE1
Coconut Oil in Treatment of Periodontitis
NCT06384638 COMPLETED PHASE1